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 PObjective. The aim of the study was to analyze the relationship between moderate-to-vigorous physicalactivity (MVPA) and insulin resistance (IR) in Spanish adults and to examine whether this relationship is
mediated by abdominal obesity (waist circumference — WC).
Methods. The cross-sectional study included 1162 healthy subjects belonging to the EVIDENT study (mean
age 55.0± 13.3 years; 61.8%women) from six different Spanish provinces. Moderate-to-vigorous physical activ-
ity (MVPA) was measured objectively over 7 days using Actigraph accelerometers, collecting data in 60-second
epochs, and retaining respondents with ≥4 valid days for the analysis. The homeostasis model of assessment
(HOMA-IR) was used to determine IR, and its individual components – fasting glucose and insulin –were deter-
mined using standard protocols. Linear regressionmodelswerefitted according to Baron andKenny's procedures
for mediation analysis.
Results. Fasting insulin and HOMA-IR levels were significantly worse in adults who spent fewer minutes in
MVPA (first quartile ≤ 30.1 and 22.7 min/day in men and women, respectively) after adjusting for age, sex,
smoking habits, drinking habits, accelerometer wear time, sedentary time, and Mediterranean diet adherence.
However, whenWCwas added to the ANCOVAmodels as a covariate, the effects disappeared.Mediation analysis
reported thatWC acts as a fullmediator in the relationship betweenMVPA and IR (HOMA-IR and fasting insulin).
Conclusion. These findings show that WC plays a pivotal role in the relationship between MVPA and IR, and
therefore highlights that decreasing abdominal obesity might be considered as an intermediate outcome for
evaluating interventions aimed at preventing diabetes mellitus.






















Physical activity is considered a protector factor against type 2 dia-
betes and cardiovascular risks (Jeon et al., 2007), and its benefits depend
on the intensity, duration, and frequency of the activity performed
(United States. Department of Health, 1996). International recommen-
dations for adults include at least 150 min/week of moderate-to-
vigorous physical activity (MVPA) or 75 min of vigorous-intensity
aerobic activity for at least 20 min 3 days a week (Haskell et al., 2007).
Previous studies have shown an inverse association between MVPA
with insulin resistance (IR) (Ekelund et al., 2009; Nelson et al., 2013)
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et al., 2006),which has shown to be an appropriate proxy for abdominal
obesity (WHO, 2008). These are both related to cardiovascular risk
(CVR) (Haffner et al., 1998; Muniyappa et al., 2008), metabolic
syndrome (Zimmet et al., 2005) and type 2 diabetes (Wareham et al.,
1999; Wilson et al., 2005). Therefore, increased MVPA levels both
decrease cardiovascular risk factors and improve the cardiometabolic
profile in the adult population.
A recent study with obese sedentary women has shown that WC
combined with cardiorespiratory fitness mediate the association
between MVPA and IR (Shalev-Goldman et al., 2013), while other
researchers have reported that this association remains unaffected
when adjusting forWC (Balkau et al., 2008; Ekelund et al., 2009). There-
fore, it seems necessary to clarify whether physical activity plays an
independent role as a protective factor of IR, or whether its influence
is mediated by changes in WC, given the close physiological link


































































































































is a statistical procedure that can be used to clarify the process underly-
ing the relationship between two variables and the extent to which this
relationship can be modified, mediated, or confounded by a third vari-
able (Baron and Kenny, 1986). Thus, the aim of this study was twofold:
i) to analyze the relationship between objectively measured MVPA and
IR in Spanish adults and ii) to examine whether this relationship is
mediated by abdominal obesity.
Subjects and methods
Study design
We conducted a cross-sectional analysis of the EVIDENT baseline
study. Our study evaluated the association of lifestyles with the
circadian pattern of blood pressure, arterial stiffness, and endothelial
function in subjects with different levels of physical activity. The proto-
col of the EVIDENT study (NCT01083082) was published elsewhere
(García-Ortiz et al., 2010).
Subjects
Subjects aged 20–80 years were selected through random sampling
from the offices of general practitioners in six primary care centers from
six different Spanish provinces (response rate ranged from 65% to 85%,
depending on the center). The exclusion criteria have been published
elsewhere (García-Ortiz et al., 2010). From the 1553 subjects included
in the EVIDENT study, 391 were excluded due to lack of HOMA-IR
(237) or accelerometer data (154), and therefore, 1162 patients were
ultimately included in the analysis.
The Research Ethics Committee of Salamanca University Hospital
(Spain) and the other centers involved approved this study. All
participants gave written informed consent according to the general
recommendations of the Declaration of Helsinki (World Medical
Association, 2013).
Measurements
A detailed description was published elsewhere detailing how the
measurements were collected (García-Ortiz et al., 2010). In short, we
measured the following variables:
Anthropometric measurements
Bodyweightwas determined on two occasions using a homologated
electronic scale (Seca 770) (precision ± 0.1 kg). Height, in turn, was
measured with a portable system (Seca 222). Body mass index (BMI)
and WC were also measured. WC was measured as follows: the upper
border of the iliac crest was located, and the tape was wrapped around
above this point, parallel to thefloor, ensuring that it was adjustedwith-
out compressing the skin. The readingwas taken at the end of a normal
breath according to the recommendations of the 2007 SEEDO Confer-
ence (Salas-Salvado et al., 2007). In order to ensure the quality and
reliability of the anthropometric measurements, the nurses responsible
for themeasurementswere trained at the start of the project.We consid-
ered WC to be normal when the value was below 94 cm in men and
80 cm in women, according to the WHO cut-off points (WHO, 2008).
Biochemical determinations
Venous blood sampling was performed between 8:00 and 9:00 AM
after the individuals had fasted (avoided smoking and the consumption
of alcohol and caffeinated beverages for the previous 12 h). Blood sam-
ples were collected in the respective health centers and were analyzed
at the hospital of the city participating in external quality assurance
programs of the Spanish Society of Clinical Chemistry and Molecular
Pathology. Fasting plasma glucose was measured using standard
enzymatic automated methods. The blood concentration of insulin
wasdetermined using a chemiluminescentmicroparticle immunoassay.Please cite this article as: García-Hermoso, A., et al., Abdominal obesity as







The insulin sensitivity was determined using the Homeostasis Model
Assessment Insulin Resistance (HOMA-IR) index with the following
formula: fasting glucose (mmol/l) × fasting insulin (mU/ml)/22.5.
Physical activity and sedentary behavior
ActiGraph GT3X accelerometers (ActiGraph, Shalimar, FL, USA)
were used to assess physical activity and sedentary behavior. This previ-
ously validated accelerometer (Matthews et al., 2013; Melanson and
Freedson, 1995) measures acceleration in three individual orthogonal
planes (vertical, anteroposterior, and medio-lateral) and provides
activity counts as a composite vector magnitude of these three axes.
Participants were verbally instructed on how to use the accelerome-
ter, which was worn fastened with an elastic band to the right side of
the waist for 7 consecutive days. All subjects were instructed to wear
the accelerometer throughout the day from the time they woke up in
the morning until they went to bed at night, except for bathing and
performing activities in the water. Wear time was determined by
subtracting non-wear time from 24 h. Non-wear time was defined as
an interval of at least 60 consecutive minutes of zero activity counts,
with allowance of up to 2 min of counts between 0 and 100. The intensity
of PAwas categorized according to the cut-off points Troiano et al. (2008)
proposed: sedentary (b100 counts/min), light (100–2019 counts/min),
moderate (2020–5998 counts/min), and vigorous (N5999 counts/min).
MVPA time was calculated as the mean daily minutes ≥ 2020 counts
per minute from all valid days.
Mediterranean diet adherence screener (MEDAS)
Adherence to the Mediterranean diet was assessed using the
validated 14-point MEDAS (Schroder et al., 2011), an adaptation of a
previously validated nine-item index. The MEDAS was developed by
the PREDIMED study group (Martinez-Gonzalez et al., 2004). The
questionnaire allows for easily estimating Mediterranean diet adher-
ence andmay be useful in clinical settings. The 14-item version includes
12 questions about food consumption frequency and two questions
about food intake habit characteristics of the Spanish Mediterranean
diet. Further information about the diet assessment is available
elsewhere (Patino-Alonso et al., 2014).
Smoking and alcohol consumption
Smoking and alcohol consumption history was assessed through
questions on smoking status (current smokers or nonsmokers) and
alcohol consumption status (current consume alcohol or not consume).
Statistical analysis
The continuous variables were expressed as the mean ± SD and
frequency distribution for categorical data. Statistical normality was
tested using both graphical (normal probability plot) and statistical
(Kolmogorov–Smirnov test) procedures. Because of their skewed distri-
bution, glucose, insulin and HOMA-IR were log-transformed (natural
logarithm) before being included in the models. To aid with interpreta-
tion, the datawere back-transformed from the log scale for presentation
in the results.
ANCOVAmodels were estimated to test the differences in the mean
of fasting plasma glucose, insulin and HOMA-IR by categories of MVPA
(low = quartile 1; medium = quartiles 2–3; high = quartile 4),
controlling for age, smoking habits, drinking habits, accelerometer
wear time, total sedentary time, and Mediterranean diet adherence in
the first step (model 1), and including WC in the second step (model
2), by sex. Pairwise post hoc comparisons were examined using the
Bonferroni test.
To examine whether the association between physical activity and
IR parameters was mediated by WC, linear regression models were
fitted using bootstrapped mediation procedures included in the
PROCESS SPSS macro (Preacher and Hayes, 2008). The first equation
regressed the mediator (WC) on the independent variable (MVPA en-
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the dependent variable (fasting glucose, fasting plasma insulin and
HOMA-IR) on the independent variable. The third equation regressed
the dependent variable on both the independent and the mediator
variables.
The following criteria were used to establish mediation: (1) the
independent variable must be significantly related to the mediator,
(2) the independent variablemust be significantly related to the depen-
dent variable, (3) the mediator must be significantly related to the
dependent variable, and (4) the association between the independent
and dependent variables must be attenuated when the mediator is in-
cluded in the regression model (Baron and Kenny, 1986). In addition,
we tested mediation using the steps Sobel (1982) outlined. First, we
estimated the attenuation or indirect influence (i.e. the influence of
the independent variable on the mediator from the first regression
model multiplied by the influence of the mediator on the dependent
variable obtained from the third regression model). Second, we divided
the indirect influence by its standard error and performed a Z test under
the null hypothesis that the indirect influence is equal to zero. This
analysis was adjusted for age, sex, smoking habits, drinking habits and
accelerometer wear time.
Statistical analyses were performed using IBM SPSS statistics
software and the level of significance was set at α = 0.05.
Results
Data were obtained from 1162 subjects (mean age 55.0 ± 13.3
years), 718 (61.8%) of whom were women. The anthropometric, IR
parameters and accelerometer descriptive data of the sample are
shown in Table 1. Most subjects (925; 80.0%) were non-smokers and
did not consume alcohol (741; 63.8%), and on average, the men and
women were 4.5 cm (for a total of 98.5 cm) and 9.2 cm above WC
cut-off point (for a total of 89.2 cm), respectively. Mean fasting plasma
glucose was higher in men than in women and the accelerometry data
showed that men did more MVPA than women.
Mean differences in IR parameters according toMVPA categories are
shown in Table 2. Men and women in the high MVPA categories had







Demographic and clinical characteristics of patients, by sex.
Total (n = 1162)
Age (years) 55.0 (13.3)
Smoking status, n (%)
Yes 237 (20.0)
No or past 925 (80.0)
Alcohol status, n (%)
Yes 421 (36.2)
No or past 741 (63.8)
Weight (kg) 72.8 (17.0)
Height (cm) 163.2 (10.2)
Body mass index (kg/m2) 27.3 (3.4)




Fasting plasma glucose (mmol/L) 5.08 (1.4)
Fasting plasma insulin (μmol/L) 7.48 (6.5)
HOMA-IR 1.75 (1.7)
Accelerometer wear time (min/day) 931.2 (218.0)
MVPA (min/day) 46.5 (28.6)
Meet recommendations for MVPA,c n (%) 527 (45.3)
VPA (min/day) 1.22 (5.4)
Sedentary time (min/day) 580.3 (175.6)
Healthy diet score (0–14) 7.4 (1.8)
Mediterranean diet adherence,b n (%) 337 (29.0)
MVPA, moderate-vigorous physical activity; VPA, vigorous physical activity.
a Values are means ± SD, except for categorical data (n (%)).
b Cut-off for obesity were waist circumference greater than 94 cm for men and 80 cm for w
c 150 min/week of MVPA (Haskell et al., 2007).
Please cite this article as: García-Hermoso, A., et al., Abdominal obesity as







in the low categories after controlling for age, smoking habits, drinking
habits, accelerometer wear time, and sedentary time. However, when
we included additional adjustment for WC (model 2), the differences
disappeared.
In both sexes, WC acted as a full mediator of the relationship be-
tween MVPA and fasting plasma insulin (Fig. 1A). Similar results were
obtained when HOMA-IR was the dependent variable in the mediation
model (Fig. 1B). The estimated percentage of total influence mediated
by WC was 12.3% in men (z = −2.03, p = 0.042) and 20.6% in
women (z = −3.07, p = 0.002) for fasting plasma insulin, and 14.1%
(z = −2.06; p = 0.039) in men and 23.2% (z = −3.13, p = 0.002) in
women for HOMA-IR. Finally, the criteria necessary for mediation
analysis were not achieved for fasting glucose levels (data not reported).
Discussion
Although a growing number of studies have examined the associa-
tion between physical activity and IR, none of them have evaluated
the mediation role of excess weight in this relationship in healthy
adults. Our results show that MVPA was negatively associated with IR
parameters, even after adjusting for sociodemographic and lifestyle po-
tential confounders, but this association disappeared when additional
adjustments for WC were included. Moreover, the mediation analysis
disclosed that the influence of MVPA on IR wasmediated by abdominal
obesity, as measured by WC.
There is consistent evidence regarding the beneficial influence of
MVPA on insulin sensitivity and glycemic control in adults, independent
of weight change (Ekelund et al., 2007; Ivy, 1997), as well as on abdom-
inal obesity, as measured byWC (Staiano et al., 2012; Stamatakis et al.,
2009). Previous studies have shown that subjects with higher values of
WC presented worse IR profiles, and those who were physically active
presented lower IR values in the same WC category compared to their
sedentary peers (Ekelund et al., 2007; Healy et al., 2006; Nelson et al.,
2013; Weinstein et al., 2004).
Some other studies have described that there is a relationship be-
tween PA and IR, independent of WC (Balkau et al., 2008; Ekelund
et al., 2009), while others have reported that the amount of physicalMena
(n = 444)
Womena (n = 718) p
57.3 (14.5) 53.5 (16.0) b0.001
83 (18.6) 154 (21.4) 0.431
361 (81.4) 564 (78.6)
116 (26.1) 305 (42.5) b0.001
328 (73.9) 413 (57.5)
81.8 (12.7) 67.2 (13.4) b0.001
170.8 (8.4) 158.6 (8.1) b0.001
28.0 (4.2) 26.8 (5.4) b0.001
98.5 (10.5) 89.2 (13.4) b0.001
291 (65.5) 572 (79.7) b0.001
153 (34.5) 146 (20.3)
5.26 (1.3) 4.96 (1.1) b0.001
7.78 (5.9) 7.30 (6.7) 0.228
1.88 (1.7) 1.68 (1.9) 0.068
941.6 (231.0) 924.8 (210.6) 0.239
53.8 (31.3) 42.0 (25.9) b0.001
233 (52.5) 294 (41.0) b0.001
2.0 (7.8) 0.7 (3.0) b0.001
601.7 (186.6) 567.2 (167.4) 0.003
7.4 (1.9) 7.5 (1.7) 0.386
120 (27.1) 217 (30.2) 0.304
omen (WHO, 2008).
















































t2:2 ANCOVA models testing differences in fasting plasma glucose, insulin, and HOMA-IR by MVPA categories, adjusting for potential confounders, by sex.





t2:4 Men Women Men Women Men Women
t2:5 Low (L) 5.44 ± 1.18 5.20 ± 1.44 9.62 ± 6.30 8.97 ± 6.86 2.46 ± 2.14 2.21 ± 2.24
t2:6 Medium (M) 5.41 ± 1.48 4.92 ± 0.79 8.41 ± 4.09 7.16 ± 5.14 2.06 ± 1.09 1.58 ± 1.13
t2:7 High (H) 5.15 ± 0.99 4.87 ± 0.76 7.24 ± 4.47 6.64 ± 5.13 1.69 ± 1.13 1.47 ± 1.18
t2:8 Model 1 p 0.139 0.223 0.030 0.001 0.004 0.002
t2:9 Post-hoc testsb ns ns L N H L N H L N H L N H
t2:10 Model 2 p 0.134 0.719 0.213 0.114 0.201 0.191
t2:11 Post-hoc testsb ns ns ns ns ns ns
t2:12 Values are means ± SD.
t2:13 Abbreviations: HOMA-IR, homeostatic model assessment of insulin resistance; MVPA, moderate-vigorous physical activity; ns, non-significant.
t2:14 Model 1: adjusted for age, smoking habit, drinking habit, accelerometerwear time, sedentary time, andMediterranean diet adherence.Model 2: adjusted for the same covariates asModel
t2:15 1 and waist circumference.
t2:16 a Log transformed for comparing means.
t2:17 b Bonferroni pairwise comparisons.
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activity was not associated with IR after controlling for WC (Shalev-
Goldman et al., 2013). Our data show that participants in the low
MVPA category had higher fasting plasma insulin and HOMA-IR levels
than did those in the higher category, but after adjusting for WC, the
relationship between MVPA and IR disappeared. Likewise, Healy et al.
(2008) found that the inverse association of MVPAwith cardiometabol-
ic risk factors did not remain significant when WC was included as a
confounder, except for triglyceride levels.
Discrepancies between studies can be explained by differences in
the populations studied (e.g. health risk status, weight status, ethnicity
and age), in themethods for physical activity assessment (e.g. calibrated
heart rate monitoring or accelerometers), and in the control of con-
founders (e.g. sedentary time, light intensity physical activity). The
main difference between our results and those presented by Shalev-
Goldman et al. (2013) is that we calculated the magnitude of WC as a
single mediator, finding that it affects individuals in the causal pathway
between MVPA and IR.
This evidence allows us to conclude that active people are more
likely to present a healthy IR and cardiometabolic profile, and thus
being physically active may help to prevent metabolic syndrome and
type 2 diabetes. It also confirms the potential mediation role of abdom-
inal obesity, as other authors have suggested (Alberti et al., 2005).







Fig. 1.WC mediation model of the relationship between MVPA (min/day), fasting insulin (1A
habits, accelerometer wear time, sedentary time, and Mediterranean diet adherence), by sex. D
Please cite this article as: García-Hermoso, A., et al., Abdominal obesity as
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R
O
Ophysical activity on improving IR is substantially greater when accom-
panied by a decrease in WC.
Furthermore, our non-significant findings for fasting plasma glucose
are in agreement with the results from most previous studies (Henson
et al., 2013; Scheers et al., 2013; Shalev-Goldman et al., 2013), and em-
phasizing that fasting plasma glucose might not be sensitive to changes
in physical activity, and two-hour plasma glucose appears to be a more
appropriate biomarker for use as an outcome measure in interventions
that are based on physical activity (Healy et al., 2008).E
DMediation analysis
Our data, by using mediation analysis, reveal that abdominal obesity
has a powerful influence on the relationship between MVPA and both
IR and fasting plasma insulin in adults. Visceral or central obesity in-
creases the flux of free fatty acids to the liver, and an important role in
the genesis of IR of these free fatty acids has been described (Petersen
et al., 2004). Inflammation has also been reported as an alternative candi-
date for the common link between central obesity and IR (Ghanim et al.,
2004). Finally, increased abdominal obesity has been associated not only
with impaired insulin sensitivity but alsowith reducedglycogen synthesis
(non-oxidative glucose disposal) and a reduced responsiveness ofmuscleB
) and HOMA-IR (1B) controlling for potential confounders (age, smoking habits, drinking
ata in roman type refer to men. Data in italics refer to women. *p ≤ 0.05; **p ≤ 0.001.
































































































































































glycogen synthase (Carey et al., 1996), all of which are related to central
obesity and an increased risk of IR.
These physiological pathways support the hypothesis that programs
aimed at increasing physical activity could diminish IR though reduc-
tions of abdominal obesity, thus you can expect a weak impact on the
insulin metabolism of those physical activity programs that, while
improving other cardiometabolic factors, fail to diminish adiposity.
Besides, the relationships analyzed here are probably related to more
than a single mediator variable (e.g. BMI, accumulated daily activity,
sedentary time); future studies using structural equations or complex
mediator model procedures might be useful in clarifying more
specifically the potential mediator or confounder role of each factor.
Finally, it might be also interesting to address how these results may
affect those subjects defined as metabolically healthy obese (MHO) vs.
metabolically unhealthy obese (MUHO) or non-obese. Previous studies
have found that MHO subjects had intermediate levels of WC (Després,
2012), a more favorable fat distribution (lower visceral fat and greater
thigh subcutaneous fat), normal levels of C-reactive protein (Phillips,
2013) and higher PA levels (Wildman et al., 2008) compared to
MUHO and non-obese subjects. A recent study in a Spanish population
(Martínez-Larrad et al., 2014) reported that the prevalence ofMHO sub-
jects was 4.78% according to Wildman modified criteria (Ascaso et al.,
2001). Thus, because of this relatively low prevalence, our coefficients'
estimationswill probably remain very similar if MHO individuals are re-
moved from the analyses, but our mediation results should be applied
with caution in these subjects, since indirect coefficients through WC
might be substantially different in this MHO phenotype.
This study has several limitations. First, the cross-sectional design
prevents us from establishing a causal relationship. For example, we
cannot establish that abdominal obesity predicts greater MVPA, since
it seems reasonable to think that many adults begin physical activity
due to an awareness of excess weight. Second, we did not use an intra-
venous glucose tolerance test or hyperinsulinemic–euglycemic clamp
technique, both considered better measures of IR (DeFronzo et al.,
1979), but instead, we used HOMA-IR, which is probably the most ap-
propriate method for measuring IR in large epidemiological studies.
Third, PA was assessed using an accelerometer during the same week,
and the fact that the subjects were evaluated with the device might
have influenced their activity levels that week. However, without any
activity goals communicated, the possible effect seems to be negligible.
Fourth, we studied subjects that were randomly selected from outpa-
tient clinics in different regions of Spain; however, the subjects may
not be representative of the general Spanish population, but rather, of
people that attend primary care centers. Wemust also take into consid-
eration the limited generalizability of the study because the participants
were people who met the rigorous inclusion criteria of the parent trial.
The generalizability is also limited because of the impossibility of
adjusting for all potential confounders, and this causes the residual con-
founding to tease out independent associations. Finally, because of the
limited amount of time spent in vigorous physical activity in our sample
(8 out of 10participants accumulatednovigorous physical activity), sta-
tistics that are similar to those reported by other authors (Ekelund et al.,
2009), itwasnot feasible to examine the relative importance of vigorous
physical activity on IR. However, we found a relationship between
insulin, IR and vigorous physical activity in men, independent of WC,
suggesting that obesity mechanisms may not be so relevant (Janssen
and Ross, 2012) in this population.
Conclusion
Our findings are important from a clinical and public health point-
of-view because they disclose that abdominal obesity plays a critical
role in the relationship between MVPA and IR, and they alert us that
physical activity only produces benefits in IR if the activity is not accom-
panied by compensatory behaviors that might mitigate its influence on
WC (e.g. less sedentary time or nutritional changes).Please cite this article as: García-Hermoso, A., et al., Abdominal obesity as
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